XML 32 R20.htm IDEA: XBRL DOCUMENT v3.20.2
Note 13 - Fair Value Measurements
6 Months Ended
Jun. 30, 2020
Notes to Financial Statements  
Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]

13. Fair Value Measurements

 

The Company determined the fair values of our financial instruments based on the following:

 

 

Level 1 - Quoted prices in active markets for identical assets or liabilities.

 

Level 2 - Observable prices in active markets for similar assets or liabilities; prices for identical or similar assets or liabilities in markets that are not active; directly observable market inputs for substantially the full term of the asset and liability; market inputs that are not directly observable but are derived from or corroborated by observable market data.

 

Level 3 – Unobservable inputs based on the Company’s own judgment about the assumptions that a market participant would use.

 

The Company uses the following methodologies to measure the fair value of its financial assets and liabilities on a recurring basis:

 

Securities Available for Sale - For certain U.S. Treasury securities, the Company measures the fair value based on quoted market prices in active exchange markets at the reporting date, a Level 1 measurement. The Company also measures securities by using quoted market prices for similar securities or dealer quotes, a Level 2 measurement. This category generally includes U.S. Government agency securities, U.S. Government sponsored entities, state and municipal securities, mortgage-backed securities (“MBS”), collateralized mortgage obligations and corporate bonds.

 

Equity Securities The Company measures the fair value based on quoted market prices in active exchange markets at the reporting date, a level 1 measurement. Equity securities are comprised of mutual funds, preferred stock of government-sponsored entities and other equity securities.

 

Foreign Exchange Contracts - The Company measures the fair value of foreign exchange contracts based on dealer quotes, a Level 2 measurement.

 

Warrants - The Company measures the fair value of warrants based on unobservable inputs based on assumptions and management judgment, a Level 3 measurement.

 

Interest Rate Swaps - Fair value of interest rate swaps is derived from third party models with observable market data, a Level 2 measurement.

 

Assets measured at estimated fair value on a non-recurring basis:

 

Certain assets or liabilities are required to be measured at estimated fair value on a nonrecurring basis subsequent to initial recognition. Generally, these adjustments are the result of lower-of-cost-or-fair value or other impairment write-downs of individual assets. In determining the estimated fair values during the period, the Company determined that substantially all the changes in estimated fair value were due to declines in market conditions versus instrument specific credit risk. For the periods ended June 30, 2020 and December 31, 2019, there were no material adjustments to fair value for the Company’s assets and liabilities measured at fair value on a nonrecurring basis in accordance with GAAP.

 

The following tables present the Company’s hierarchy for its assets and liabilities measured at fair value on a recurring basis as of June 30, 2020, and December 31, 2019:

 

   

June 30, 2020

         
   

Fair Value Measurements Using

   

Total Fair Value

 
   

Level 1

   

Level 2

   

Level 3

   

Measurements

 
   

(In thousands)

 

Assets

                               

Securities available-for-sale

                               

U.S. Treasury securities

  $ 99,927     $     $     $ 99,927  

U.S. government agency entities

          107,393             107,393  

Mortgage-backed securities

          802,412             802,412  

Collateralized mortgage obligations

          301             301  

Corporate debt securities

          136,069             136,069  

Total securities available-for-sale

  $ 99,927     $ 1,046,175     $     $ 1,146,102  
                                 

Equity securities

                               

Mutual funds

  $ 6,431     $     $     $ 6,431  

Preferred stock of government sponsored entities

    4,868                   4,868  

Other equity securities

    13,271                   13,271  

Total equity securities

  $ 24,570     $     $     $ 24,570  
                                 

Warrants

  $     $     $ 13     $ 13  

Interest rate swaps

          3,842             3,842  

Foreign exchange contracts

          1,529             1,529  

Total assets

  $ 124,497     $ 1,051,546     $ 13     $ 1,176,056  
                                 

Liabilities

                               

Option contracts

  $     $ 6     $     $ 6  

Interest rate swaps

          33,760             33,760  

Foreign exchange contracts

          531             531  

Total liabilities

  $     $ 34,297     $     $ 34,297  

 

 

   

December 31, 2019

         
   

Fair Value Measurements Using

   

Total Fair Value

 
   

Level 1

   

Level 2

   

Level 3

   

Measurements

 
   

(In thousands)

 

Assets

                               

Securities available-for-sale

                               

U.S. Treasury securities

  $ 74,936     $     $     $ 74,936  

U.S. government agency entities

          90,796             90,796  

U.S. government sponsored entities

          224,443             224,443  

Mortgage-backed securities

          887,790             887,790  

Collateralized mortgage obligations

          552             552  

Corporate debt securities

          173,325             173,325  

Total securities available-for-sale

  $ 74,936     $ 1,376,906     $     $ 1,451,842  
                                 

Equity securities

                               

Mutual funds

  $ 6,277     $     $     $ 6,277  

Preferred stock of government sponsored entities

    10,529                   10,529  

Other equity securities

    11,199                   11,199  

Total equity securities

  $ 28,005     $     $     $ 28,005  
                                 

Warrants

  $     $     $ 39     $ 39  

Interest rate swaps

          2,181             2,181  

Foreign exchange contracts

          2,411             2,411  

Total assets

  $ 102,941     $ 1,381,498     $ 39     $ 1,484,478  
                                 

Liabilities

                               

Option contracts

  $     $ 7     $     $ 7  

Interest rate swaps

          14,229             14,229  

Foreign exchange contracts

          1,415             1,415  

Total liabilities

  $     $ 15,651     $     $ 15,651  

 

The Company measured the fair value of its warrants on a recurring basis using significant unobservable inputs. The fair value adjustment of warrants was included in other operating income in the first six months of 2020. The significant unobservable inputs in the Black-Scholes option pricing model for the fair value of warrants are their expected life ranging from 1 to 5 years, risk-free interest rate from 0.29% to 0.60%, and stock volatility from 16.61% to 23.26%.

 

For financial assets measured at fair value on a nonrecurring basis that were still reflected in the Condensed Consolidated Balance Sheets as of June 30, 2020, the following tables set forth the level of valuation assumptions used to determine each adjustment, the carrying value of the related individual assets as of June 30, 2020, and December 31, 2019, and the total losses for the periods indicated:

 

   

As of June 30, 2020

   

Total Losses

 
   

Fair Value Measurements Using

   

Total Fair

   

For the Three Months Ended

   

For the Six Months Ended

 
   

Level 1

   

Level 2

   

Level 3

   

Value

Measurements

   

June 30, 2020

   

June 30, 2019

   

June 30, 2020

   

June 30, 2019

 
   

(In thousands)

 

Assets

                                                               

Impaired loans by type:

                                                               

Commercial loans

  $     $     $ 8,968     $ 8,968     $     $     $     $  

Commercial mortgage loans

                19,439       19,439                          

Residential mortgage loans and equity lines

                8,974       8,974                          

Total impaired loans

                37,381       37,381                          

Other real estate owned (1) 

          3,405       4,238       7,643       381       422       717       494  

Investments in venture capital and private company stock

                1,384       1,384       71       16       104       18  

Total assets

  $     $ 3,405     $ 43,003     $ 46,408     $ 452     $ 438     $ 821     $ 512  

 

(1) Other real estate owned balance of $7.3 million in the condensed consolidated balance sheet is net of estimated disposal costs. 

 

   

As of December 31, 2019

   

Total Losses/(Gains)

 
   

Fair Value Measurements Using

   

Total Fair

   

For the Twelve Months Ended

 
   

Level 1

   

Level 2

   

Level 3

   

Value

Measurements

   

December 31, 2019

   

December 31, 2018

 
   

(In thousands)

 

Assets

                                               

Impaired loans by type:

                                               

Commercial loans

  $     $     $ 6,196     $ 6,196     $     $  

Commercial mortgage loans

                25,566       25,566              

Residential mortgage loans and equity lines

                5,320       5,320              

Total impaired loans

                37,082       37,082              

Other real estate owned (1)

          6,490       4,343       10,833       681       (619 )

Investments in venture capital and private company stock

                1,604       1,604       167       330  

Total assets

  $     $ 6,490     $ 43,029     $ 49,519     $ 848     $ (289 )

 

(1) Other real estate owned balance of $10.2 million in the Consolidated Balance Sheets is net of estimated disposal costs. 

 

The significant unobservable (Level 3) inputs used in the fair value measurement of collateral for collateral-dependent impaired loans are primarily based on the appraised value of collateral adjusted by estimated sales cost and commissions. The Company generally obtains new appraisal reports every twelve months as appropriate. As the Company’s primary objective in the event of default would be to monetize the collateral to settle the outstanding balance of the loan, less marketable collateral would receive a larger discount. In the current year, the Company used borrower specific collateral discounts with various discount levels.

 

The significant unobservable inputs used in the fair value measurement of other real estate owned (“OREO”) are primarily based on the appraised value of OREO adjusted by estimated sales cost and commissions. The Company applies estimated sales cost and commissions ranging from 3% to 6% of the collateral value of impaired loans, quoted price, or loan sale price of loans held for sale, and appraised value of OREO.